Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Controlled Trial of MRI Target Biopsy: Transrectal vs. Transperineal

NCT03650153 is registered in ClinicalTrials.gov with Princess Al-Johara Al-Ibrahim Cancer Research Center as lead sponsor.

NCT NCT03650153
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03650153 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Controlled Trial of MRI Target Biopsy: Transrectal vs. Transperineal
Lead sponsor
Princess Al-Johara Al-Ibrahim Cancer Research Center
Phase
Not applicable
Overall status
Completed
Start date
January 1, 2020
Completion date
December 31, 2022
Enrollment
165 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer